基本信息
浏览量:0
职业迁徙
个人简介
His research interest lies in understanding the molecular basis for human tumor development and how to use this knowledge to devise new therapeutics that will improve patient survival. Van Meir's research examines how genetic alterations and hypoxia induce changes in cell biology that promote tumor formation with particular emphasis on heterotypic cell-cell signaling, including tumor angiogenesis. Van Meir has developed novel therapeutic approaches for cancer using oncolytic adenoviruses and anti-angiogenic molecules and is currently developing novel small molecule inhibitors of the hypoxia-inducible factor pathway. His research aims to translate these novel agents to testing in clinical trials with the hope to develop novel medicines for cancer treatment. The principal modeling systems he uses in his lab are malignant brain (glioblastoma and medulloblastoma) and eye (metastatic uveal melanoma) cancers, although the experimental therapeutics he develops are applicable to the cure of many solid malignancies.
研究兴趣
论文共 361 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Tathiane M. Malta,Thais S. Sabedot, Natalia S. Morosini,Indrani Datta,Luciano Garofano,Wies Vallentgoed,Frederick S. Varn,Kenneth Aldape, Fulvio D'Angelo,Spyridon Bakas,Jill S. Barnholtz-Sloan,Hui K. Gan,
CANCER RESEARCHno. 5 (2024): 741-756
Cancer Researchno. 7_Supplement (2023): 485-485
引用0浏览0引用
0
0
Yuan Rong, Vladimir E. Belozerov,Carol Tucker-Burden, Gang Chen,Donald L. Durden, Jeffrey J. Olson,Erwin G. Van Meir,Nigel Mackman,Daniel J. Brat
crossref(2023)
Neuro-oncologyno. Supplement_5 (2023): v46-v46
引用0浏览0引用
0
0
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn